|

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

RECRUITINGPhase 1Sponsored by South Plains Oncology Consortium
Actively Recruiting
PhasePhase 1
SponsorSouth Plains Oncology Consortium
Started2013-12
Est. completion2026-12
Eligibility
Age12 Months – 20 Years
Healthy vol.Accepted
Locations5 sites

Summary

This is a Phase 1 study of the combination of two drugs: MM-398 and Cyclophosphamide. The goal is to find the highest dose of MM-398 that can be given safely when it is used together with the chemotherapy drug Cyclophosphamide.

Eligibility

Age: 12 Months – 20 YearsHealthy volunteers accepted
Inclusion Criteria:

* Histologically or cytologically-confirmed Ewing sarcoma, rhabdomyosarcoma, neuroblastoma, or osteosarcoma
* Disease progression after prior therapy in locally advanced or metastatic setting
* Measurable or evaluable disease based on the Response Evaluation Criteria in Solid Tumors (RECIST v1.1) criteria
* Age 12 months to \<21 years
* Adequate bone marrow reserves, hepatic function, and renal function
* Recovered from effects of any prior surgery or cancer therapy
* Patients 18 years or older will provide written consent. A parent or legal guardian of a patient \<18 years of age will provide informed consent and patients 11 to 18 years of age will provide written assent or as per participating institutional policy.

Exclusion Criteria:

* Clinically significant gastrointestinal disorders
* NYHA Class III or IV congestive heart failure, ventricular arrhythmias or uncontrolled blood pressure
* Active infection or unexplained fever
* Known hypersensitivity to any of the components of MM-398 or other liposomal products
* Recent Investigational therapy
* Pregnant or breast feeding; females of child-bearing potential must test negative for pregnancy at the time of enrollment

Conditions6

CancerEwing SarcomaNeuroblastomaOsteosarcomaRecurrent or Refractory Solid TumorsRhabdomyosarcoma

Locations5 sites

Ohio

1 site
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
513-636-4200

Oklahoma

1 site
University Of Oklahoma Health Sciences Center
Haley Jones

Texas

2 sites
UT Southwestern
Dallas, Texas, 75235
Alison Patterson
Texas Tech University Health Sciences Center
Lubbock, Texas, 79430
Liza Villarreal806-775-8590liza.villarreal@ttuhsc.edu

Wisconsin

1 site
Midwest Children's Hospital
Sophia Root414-955-5025sroot@mcw.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.